CORRESP 1 filename1.htm amix20250929_corresp.htm

 

Autonomix Medical, Inc.

21 Waterway Avenue, Suite 300

The Woodlands, Texas 77380

 

 

September 29, 2025

 

VIA EDGAR

 

U.S. Securities and Exchange Commission

Division of Corporate Finance

Washington, DC 20549

 

 

Re:

Autonomix Medical, Inc.

Registration Statement on Form S-1

Registration No. 333-290472

 

Ladies and Gentlemen:

 

Pursuant to Rule 461 of the Securities Act of 1933, as amended, Autonomix Medical, Inc., a Delaware corporation (the “Company”), hereby respectfully requests that the effective date for the Registration Statement referred to above be accelerated so that it will be declared effective at 4:00 P.M. (Eastern Time) on September 30, 2025, or as soon thereafter as possible on such date.

 

 

  Very truly yours,  
       
  Autonomix Medical, Inc.  
       
       
       
  By: /s/ Trent Smith  
    Name: Trent Smith  
    Title: Chief Financial Officer